SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Ipca Laboratories Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524494 INE571A01038 244.5848347 IPCALAB 0.31 32,669.49 59.34 21.7 1
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales1506.831662.671486.34
Other Operating Income0.000.000.00
Other Income 16.8936.1443.16
Total Income1523.721698.811529.50
Total Expenditure 1233.341353.691188.81
PBIDT290.38345.12340.69
Interest 27.2138.6430.76
PBDT263.17306.48309.93
Depreciation63.0261.3560.35
Tax62.1084.0080.00
Fringe Benefit Tax0.000.000.00
Deferred Tax1.11-1.003.00
Reported Profit After Tax136.94162.13166.58
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item136.94162.13166.58
    
EPS (Unit Curr.)5.406.396.57
EPS (Adj) (Unit Curr.)5.406.396.57
Calculated EPS (Unit Curr.)5.406.396.57
Calculated EPS (Adj) (Unit Curr.)5.406.396.57
Calculated EPS (Ann.) (Unit Curr.)21.5925.5626.26
Calculated EPS (Adj) (Ann.) (Unit Curr.)21.5925.5626.26
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.00200.000.00
Equity25.3725.3725.37
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)19.2720.7622.92
PBDTM(%)17.4718.4320.85
PATM(%)9.099.7511.21